Literature DB >> 23393673

Periodontal disease and diabetes.

Antonio Bascones-Martínez1, Santiago Arias-Herrera, Elena Criado-Cámara, Jaime Bascones-Ilundáin, Cristina Bascones-Ilundáin.   

Abstract

Diabetes is considered to be a genetically and environmentally based chronic metabolic and vascular syndrome caused by a partial or total insulin deficiency with alteration in the metabolism of lipids, carbohydrates and proteins culminating with different manifestations in different organisms. In humans hyperglycemia is the main consequence of defects in the secretion and/or action of insulin, and its deregulation can produce secondary lesions in various organs, especially kidneys, eyes, nerves, blood vessels and immune systems. Periodontal disease is an entity of localized infection that involves tooth-supporting tissues. The first clinical manifestation of periodontal disease is the appearance of periodontal pockets, which offer a favorable niche for bacterial colonization. The etiology of periodontal disease is multifactorial, being caused by interactions between multiple micro-organisms (necessary but not sufficient primary etiologic factors), a host with some degree of susceptibility and environmental factors. According to current scientific evidence, there is a symbiotic relationship between diabetes and periodontitis, such that diabetes is associated with an increased incidence and progression of periodontitis, and periodontal infection is associated with poor glycaemic control in diabetes due to poor immune systems. Hence, for a good periodontal control it is necessary to treat both periodontal disease and glycaemic control.

Entities:  

Mesh:

Year:  2012        PMID: 23393673     DOI: 10.1007/978-1-4614-5441-0_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

1.  Bacterial infection increases periodontal bone loss in diabetic rats through enhanced apoptosis.

Authors:  Sandra Pacios; Oelisoa Andriankaja; Jun Kang; Maher Alnammary; Jason Bae; Beatriz de Brito Bezerra; Helen Schreiner; Daniel H Fine; Dana T Graves
Journal:  Am J Pathol       Date:  2013-10-08       Impact factor: 4.307

2.  Author's reply: Salivary tumor necrosis factor-alpha: The way ahead.

Authors:  Pritma Singh; Narinder Dev Gupta; Afshan Bey; Saif Khan
Journal:  J Indian Soc Periodontol       Date:  2015 Mar-Apr

Review 3.  Effect of non-surgical periodontal treatment on glycemic control of patients with diabetes: a meta-analysis of randomized controlled trials.

Authors:  Quan Li; Sha Hao; Jie Fang; Jing Xie; Xiang-Hui Kong; Jian-Xin Yang
Journal:  Trials       Date:  2015-07-03       Impact factor: 2.279

4.  Effect of β-anhydroicaritin on the expression levels of tumor necrosis factor-α and matrix metalloproteinase-3 in periodontal tissue of diabetic rats.

Authors:  Yingtao Wu; Wanchun Wang; Lian Liu
Journal:  Mol Med Rep       Date:  2015-04-02       Impact factor: 2.952

5.  Periodontal Treatment and the Risks of Cardiovascular Disease in Patients with Type 2 Diabetes: A Retrospective Cohort Study.

Authors:  Chiung-Huei Peng; Yi-Sun Yang; Kuei-Chuan Chan; Edy Kornelius; Jeng-Yuan Chiou; Chien-Ning Huang
Journal:  Intern Med       Date:  2017-05-01       Impact factor: 1.271

6.  High Glucose Concentration Promotes Vancomycin-Enhanced Biofilm Formation of Vancomycin-Non-Susceptible Staphylococcus aureus in Diabetic Mice.

Authors:  Chi-Yu Hsu; Jwu-Ching Shu; Mei-Hui Lin; Kowit-Yu Chong; Chien-Cheng Chen; Shu-Min Wen; Yi-Ting Hsieh; Wan-Ting Liao
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

7.  Systems approaches to computational modeling of the oral microbiome.

Authors:  Dimiter V Dimitrov; Julia Hoeng
Journal:  Front Physiol       Date:  2013-07-10       Impact factor: 4.566

8.  Expression of programmed death 1 ligand 1 on periodontal tissue cells as a possible protective feedback mechanism against periodontal tissue destruction.

Authors:  Jiehua Zhang; Chieh-Mei Wang; Ping Zhang; Xiaoqian Wang; Jiao Chen; Jun Yang; Wanlu Lu; Wenjie Zhou; Wenwen Yuan; Yun Feng
Journal:  Mol Med Rep       Date:  2016-01-28       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.